Initiator Pharma selects Syngene and Research Toxicology Centre (RTC) as primary partners for the preclinical development of IPED2015.

Cision News-19/04/2017. Initiator Pharma has selected Syngene, India and Research Toxicology Centre, Italy ( RTC) as contract research organizations (CROs) to conduct the pre-clinical development of the drug candidate IPED2015 for the treatment of ED.

• Read more